by Commetric | Jan 20, 2023
The annual healthcare takeover of San Francisco is arguably still the most influential gathering in the business, as it generally sets the tone for the year for the drug industry. Our media analysis found that despite a slowdown, M&A still gives pharma brands a PR...
by Commetric | Sep 26, 2022
This year’s European Society for Medical Oncology (ESMO) Congress was closely followed by specialised pharma outlets and managed to generate interest in daily media as well. Our media analysis found that a new study linking pollution...
![EHA 2022: What Hematology Trends Attracted Media Attention [Infographic]](https://commetric.com/wp-content/uploads/2022/07/EHACongress2022-Infographic.jpg)
by Commetric | Jul 27, 2022
The European Hematology Association’s (EHA) 2022 Hybrid Congress was covered widely by specialised pharma media outlets like Hematology Advisor, Fierce Biotech and Medscape, as well as some business publications like Reuters and Seeking Alpha. To see what stood out...
by Commetric | Jul 22, 2022
The European Hematology Association’s 2022 Congress saw many pharma companies present their latest work in blood cancer research. Our analysis found that lymphoma became the focus of the media debate around EHA 2022, while companies that reported M&A deals...
by Commetric | Jul 4, 2022
The first meeting of the American Society of Clinical Oncology since the start of the pandemic was covered by many pharma publications which followed a wealth of exciting data across the oncology spectrum. Our media analysis found that ASCO gave rise to a new...
